Description: Section I: Essentials in Common Therapeutic Decisions.Chapter 1: Introductions to Clinial Pharmacology.Chapter 2: Treatment of Cardiovascular Disorders: Hypertension.Chapter 3: Treatment of Cerdiovascular Disorders: Orthostatic Hypotension.Chapter 4: Treatment of Cardiovascular Disorders: Congestive Heart Failure.Chapter 5:Treatment of Cardiovascular Disorders:Ischemic Heart Disease.Chapter 6: Treatment of Cardiovascular Disorders: Arrhythmias.Chapter 7: Pulmonary Disorders.Chapter 8: Gastrointestinal Disorders.Chapter 9: Treatment of Hepatic Disorders and the Influence of Liver Function on Drug Disposition.Chapter 10: Nutrition.Chapter 11: Treatment of Remal Disorders and the Influence of Renal Function on Drug Disposition.Chapter 12: Neurologic Disorders.Chapter 13: Psychiatric Disorders.Chapter 14: Treatment of Endiocrine Disorders: The Thyroid.Chapter 15: Treatment of endocrine Disorders: Lipids.Chapter 16: Treatment of Endocrine Disorders: Diabetes Mellitus.Chapter 17: Treatment of Endocrine Disorders: Estrogens and Progestins.Chapter 18: Treatment of Endocrine Disorders: Hypothalamic Hormones.Chapter 19: Rheumatic Disorders.Chapter 20: Metabolic and Degenerative disorders of Connective Tissue and Bone.Chapter 21: Dermatologic Disorders.Chapter 22: Hematologic Disorders.Chapter 23: Antineoplastic Drugs.Chapter 24: Infectious Disorders.Chapter 25: Analgesia and Anesthesia.Chapter 26: Treatment in the Intensive Care Unit.Chapter 27: Substance Abuse: Dependence and Treatment.Chapter 28: Management of Poisoning.Section II: Core Material of Clinial Pharmacology.Chapter 29: Drugs in Special Patient Groups: Pregnancy and Nursing.Chapter 30: Drugs in Special Patient Groups: Neonates and Children.Chapter 31: Drugs in special Patient Groups: The Elderly.Chapter 32: Drugs in Special Patient Groups: Clinical Importance of Genetics in Drug Effects.Chapter 33: Prescriptions.Chapter 34: Drug Recovery and Development.Chapter 35: Risk in Taking Drugs.Chapter 36: The Clinician's Actions When N = 1.Chapter 37: Clinical Pharmacokinetics and Pharmacodynamics.Chpater 38: Variability and Control Strategies in Quantitative Therapeutics.Chapter 39: Adverse Drug Reactions.Chapter 40: Drug Interactions.Chapter 41: a Clinical Epidemiologic Approach to Therapeutics.Appendix I.Appendix II.42: Drug Discovery and

Please Wait